Growing community of inventors

Shanghai, China

Kangze Dai

Average Co-Inventor Count = 17.99

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Kangze DaiXin Wang (1 patent)Kangze DaiTao Wang (1 patent)Kangze DaiLu Chen (1 patent)Kangze DaiClinton Scott Shultz (1 patent)Kangze DaiJungchul Kim (1 patent)Kangze DaiTeng Li (1 patent)Kangze DaiTaotao Lu (1 patent)Kangze DaiJoshua Lee (1 patent)Kangze DaiEric M Phillips (1 patent)Kangze DaiZhiwei Chen (1 patent)Kangze DaiHaiheng Guo (1 patent)Kangze DaiHet P Patel (1 patent)Kangze DaiPatrick Larpent (1 patent)Kangze DaiChintal Desai (1 patent)Kangze DaiNastaran Salehi Marzijarani (1 patent)Kangze DaiStephen M Dalby (1 patent)Kangze DaiJianjun Duan (1 patent)Kangze DaiKangze Dai (1 patent)Xin WangXin Wang (67 patents)Tao WangTao Wang (14 patents)Lu ChenLu Chen (10 patents)Clinton Scott ShultzClinton Scott Shultz (3 patents)Jungchul KimJungchul Kim (3 patents)Teng LiTeng Li (2 patents)Taotao LuTaotao Lu (1 patent)Joshua LeeJoshua Lee (1 patent)Eric M PhillipsEric M Phillips (1 patent)Zhiwei ChenZhiwei Chen (1 patent)Haiheng GuoHaiheng Guo (1 patent)Het P PatelHet P Patel (1 patent)Patrick LarpentPatrick Larpent (1 patent)Chintal DesaiChintal Desai (1 patent)Nastaran Salehi MarzijaraniNastaran Salehi Marzijarani (1 patent)Stephen M DalbyStephen M Dalby (1 patent)Jianjun DuanJianjun Duan (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Merck Sharp + Dohme Corp. (1 from 2,405 patents)

2. Werthenstein Biopharma Gmbh (1 from 2 patents)


1 patent:

1. 11827614 - Synthetic pathway to belzutifan and crystalline phases of synthetic intermediates

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/27/2025
Loading…